Described herein are shunt devices configured to achieve a targeted reduction in peak systolic pressure by percutaneously
shunting from the
superior vena cava to the
right pulmonary artery. The shunt devices include a
check valve with a
cracking pressure to preserve a minimal transpulmonary pressure. Also described herein are
flow diversion devices placed between pulmonary circulation vessels and venous vessels. The disclosed
flow diversion devices are physiologically responsive through an adjustable orifice that can be adjusted after initial implantation through a non-invasive or minimally
invasive procedure. Disclosed herein are flow control systems that are configured to reduce recruitment of blood from the splanchnic
system. The flow control systems include a variable orifice constrictor (e.g., a
covered stent) and a controller that delivers energy to the constrictor to reduce the cross-sectional area of the lumen through the variable orifice constrictor.